檢索結果 - Andrea Kuendgen

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Valproic acid for the treatment of myeloid malignancies

    Valproic acid for the treatment of myeloid malignancies 由 Andrea Kuendgen, Norbert Gattermann

    出版 2007
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  2. 2
    Myelodysplastic Syndromes in Patients Younger Than Age 50

    Myelodysplastic Syndromes in Patients Younger Than Age 50 由 Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid 由 Andrea Kuendgen, Corinna Strupp, Manuel Aivado, A. Bernhardt, Barbara Hildebrandt, Rainer Haas, Ulrich Germing, Norbert Gattermann

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes 由 Judith Neukirchen, Sabine Blum, Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia 由 Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

    Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis 由 Andrea Kuendgen, Michael Lauseker, Alan F. List, Pierre Fenaux, Aristoteles Giagounidis, Nancy A. Brandenburg, Jay T. Backstrom, Axel Glasmacher, Joerg Hasford, Ulrich Germing

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

    Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes 由 Akira Matsuda, Ulrich Germing, Itsuro Jinnai, Motohiro Misumi, Andrea Kuendgen, Sabine Knipp, Manuel Aivado, Masako Iwanaga, Yasushi Miyazaki, Hideki Tsushima, Mari Sakai, Masami Bessho, Masao Tomonaga

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia

    Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia 由 Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux, Mikkael A. Sekeres, Jeff Szer, Uwe Platzbecker, Andrea Kuendgen, Gianluca Gaïdano, W Wiktor-Jędrzejczak, Kuolung Hu, Paul Woodard, Allen S. Yang, Hagop M. Kantarjian

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature

    Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review... 由 Andrea Kuendgen, Catharina Müller‐Thomas, Michael Lauseker, Torsten Haferlach, Petra Urbaniak, Thomas Schroeder, Carolin Brings, Michael Wulfert, Manja Meggendorfer, Barbara Hildebrandt, Beate Betz, Brigitte Royer‐Pokora, Norbert Gattermann, Rainer Haas, Ulrich Germing, Katharina S. Götze

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

    A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy 由 Michael Lübbert, Björn Rüter, Rainer Claus, Claudia Schmoor, Mathias Schmid, Ulrich Germing, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, Uwe Platzbecker, Oliver Galm, Wolfram Brugger, Gerhard Heil, Björn Hackanson, Barbara Deschler-Baier, Konstanze Döhner, A Hagemeijer, P. Wijermans, Hartmut Döhner

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Dynamics of Mortality and Transformation Risk within Different Risk Groups of Patients with Myelodysplastic Syndromes Stratified According to the IPSS-R - Comparison of Treated and Untreated Patients and Consequences for the Description of Risk Categories

    Dynamics of Mortality and Transformation Risk within Different Risk Groups of Patients with Myelodysplastic Syndromes Stratified According to the IPSS-R - Comparison of Treated and... 由 Michael Pfeilstöcker, Heinz Tuechler, Lionel Adès, Jaroslav Čermák, Fatiha Chermat, Matteo Giovanni Della Porta, Pierre Fenaux, Guillermo Garcia‐Manero, Ulrich Germing, Detlef Haase, Andrea Kuendgen, Michael Luebbert, Sílvia Maria Meira Magalhães, Luca Malcovati, Yasushi Miyazaki, Guillermo Sanz, Valeria Santini, Mikkael A. Sekeres, Matthew J. Walter, Peter Valent, Peter L. Greenberg

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

    Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) 由 Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Anja Stölzle, Daniela Späth, Andrea Kuendgen, Marie von Lilienfeld‐Toal, Wolfram Brugger, Hans Günter Derigs, Stephan Kremers, Richard Greil, Aruna Raghavachar, Mark Ringhoffer, Helmut R. Salih, Mohammed Wattad, Heinz Kirchen, Volker Runde, Gerhard Heil, Andreas Petzer, Michael Girschikofsky, Michael Heuser, Sabine Käyser, Gudrun Goehring, Maria‐Veronica Teleanu, Brigitte Schlegelberger, Arnold Ganser, Jürgen Krauter, Lars Bullinger, Hartmut Döhner, Konstanze Döhner

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Revised International Prognostic Scoring System for Myelodysplastic Syndromes 由 Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Otto Krieger, Michael Luebbert, Jaroslaw P. Maciejewski, Silvia M. M. Magalhães, Yasushi Miyazaki, Michael Pfeilstöcker, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

    Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes 由 Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Otto Krieger, Michael Luebbert, Jaroslaw P. Maciejewski, Silvia M. M. Magalhães, Yasushi Miyazaki, Michael Pfeilstöcker, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase

    出版 2016
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  15. 15
    Time-dependent changes in mortality and transformation risk in MDS

    Time-dependent changes in mortality and transformation risk in MDS 由 Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Alessandro Levis, Michael Luebbert, Jaroslaw P. Maciejewski, Sigrid Machherndl‐Spandl, Silvia M. M. Magalhães, Yasushi Miyazaki, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase, Peter L. Greenberg

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

    Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS 由 Yasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, F. Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Valeria Santini, Michael Lübbert, Jaroslaw P. Maciejewski, Sigrid Machherndl‐Spandl, Silvia M. M. Magalhães, Michael Pfeilstöcker, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase, Peter L. Greenberg

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

    Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS 由 Andrea Kuendgen, Meritxell Nomdedéu, Heinz Tuechler, Guillermo Garcia‐Manero, Rami S. Komrokji, Mikkael A. Sekeres, Matteo Giovanni Della Porta, Mario Cazzola, Amy E. DeZern, Gail J. Roboz, David P. Steensma, Arjan A. van de Loosdrecht, Richard F. Schlenk, Javier Grau, Xavier Calvo, Sabine Blum, Arturo Pereira, Peter Valent, Dolors Costa, Aristoteles Giagounidis, Blanca Xicoy, Hartmut Döhner, Uwe Platzbecker, Carme Pedro, Michael Lübbert, I. Oiartzabal, María Díez‐Campelo, María‐Teresa Cedena, Sigrid Machherndl‐Spandl, Maria López‐Pavía, Claudia D. Baldus, Montserra Martinez-de-Sola, Reinhard Stauder, Brayan Merchán, Alan F. List, Christina Ganster, Thomas Schroeder, Maria Teresa Voso, Michael Pfeilstöcker, Heinz Sill, Barbara Hildebrandt, Jordi Esteve, Benet Nomdedeu, Francesc Cobo, Rainer Haas, Françesc Solé, Ulrich Germing, Peter L. Greenberg, Dagmar Haase, Guillermo Sanz

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: